Provectus Biopharmaceuticals, Inc. SEC filings PVCT
Provectus Biopharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 2, 2026 | Jan 30, 2026 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Jun 18, 2025 | — |
| 10-K/A | Amended annual report | May 16, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | May 5, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | May 1, 2025 | Apr 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 16, 2025 | Apr 15, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 22, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 26, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| D | Filing | Jul 17, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 17, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Jun 25, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | May 9, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | May 6, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 16, 2024 | Apr 10, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 27, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2024 | Feb 15, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| DEFA14A | Additional proxy material | Jun 21, 2023 | — |
| ARS | Annual report to shareholders | May 11, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2023 | Apr 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2023 | Apr 17, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 12, 2022 | Dec 12, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| D | Filing | Oct 28, 2022 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 26, 2022 | Sep 20, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 22, 2022 |
| DEFA14A | Additional proxy material | Jun 22, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2022 | Jun 22, 2022 |
| DEFA14A | Additional proxy material | Jun 6, 2022 | — |
| DEFA14A | Additional proxy material | May 26, 2022 | — |
| DEFA14A | Additional proxy material | May 19, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Other events
|
Apr 19, 2022 | Apr 19, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2022 | Apr 19, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 5, 2022 | Mar 30, 2022 |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 7, 2021 | Aug 25, 2021 |
| D | Filing | Aug 30, 2021 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 18, 2021 | Aug 13, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jun 24, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2021 | Jun 23, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Apr 29, 2021 |
| 10-K | Annual report | Mar 2, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 16, 2020 | Jul 11, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2020 | Jun 24, 2020 |
| 10-Q | Quarterly report | May 13, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Apr 28, 2020 |
| 10-K | Annual report | Mar 5, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Jan 7, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Dec 26, 2019 | Dec 20, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2019 | Jun 26, 2019 |
| 8-K |
Current report
Officer or director change
|
May 20, 2019 | May 17, 2019 |
| DEFA14A | Additional proxy material | May 14, 2019 | — |
| DEF 14A | Proxy statement | May 14, 2019 | May 14, 2019 |
| 10-Q | Quarterly report | May 13, 2019 | Mar 31, 2019 |
| 10-K/A | Amended annual report | May 9, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change
|
May 9, 2019 | May 8, 2019 |
| 8-K |
Current report
Officer or director change
|
May 2, 2019 | Apr 29, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2019 | Mar 25, 2019 |
| 10-K | Annual report | Mar 7, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2019 | Jan 24, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2018 | Nov 26, 2018 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 30, 2018 | Jul 26, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2018 | Jun 27, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2018 | Jun 27, 2018 |
| 10-Q | Quarterly report | May 9, 2018 | Mar 31, 2018 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Apr 30, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 24, 2018 | Apr 19, 2018 |
| 8-K |
Current report
Other events
|
Apr 6, 2018 | Apr 5, 2018 |
| 10-K | Annual report | Mar 23, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 26, 2018 | Feb 23, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2018 | Feb 22, 2018 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jan 30, 2018 | Jan 25, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2017 | Dec 12, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2017 | Nov 30, 2017 |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2017 | Oct 18, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 21, 2017 | Sep 21, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 8-K |
Current report
Other events
|
Aug 1, 2017 | Jul 25, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2017 | May 30, 2017 |
| 10-Q | Quarterly report | May 10, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Listing notice
|
Apr 27, 2017 | Apr 21, 2017 |
| DEF 14A | Proxy statement | Apr 27, 2017 | May 30, 2017 |
| DFAN14A | Filing | Apr 21, 2017 | — |
| 25-NSE | Delisting notice | Apr 21, 2017 | — |
| 25-NSE | Delisting notice | Apr 21, 2017 | — |
| PRER14A | Filing | Apr 20, 2017 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 20, 2017 | Apr 19, 2017 |
| DFAN14A | Filing | Apr 19, 2017 | — |
| 8-K |
Current report
Other events
|
Apr 18, 2017 | Apr 12, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2017 | May 30, 2017 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change, Regulation FD disclosure
|
Apr 4, 2017 | Apr 3, 2017 |
| 10-K | Annual report | Mar 31, 2017 | Dec 31, 2016 |
| 8-K |
Current report
Other events
|
Mar 30, 2017 | Mar 30, 2017 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 23, 2017 | Mar 19, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2017 | Mar 20, 2017 |
| NT 10-K | Filing | Mar 16, 2017 | Dec 31, 2016 |
| 424B3 | Prospectus | Mar 6, 2017 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 6, 2017 | Mar 6, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2017 | Feb 24, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2017 | Feb 23, 2017 |
| 424B3 | Prospectus | Feb 21, 2017 | — |
| 8-K |
Current report
Material agreement, New debt
|
Feb 21, 2017 | Feb 21, 2017 |
| 8-K |
Current report
Other events
|
Feb 14, 2017 | Feb 13, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 13, 2017 | Feb 10, 2017 |
| 424B3 | Prospectus | Feb 9, 2017 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2017 | Feb 9, 2017 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Feb 3, 2017 | Jan 30, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 31, 2017 | Jan 31, 2017 |
| 424B4 | Prospectus | Jan 31, 2017 | — |
| EFFECT | Filing | Jan 27, 2017 | — |
| CORRESP | Letter to the SEC | Jan 27, 2017 | — |
| DEFA14A | Additional proxy material | Jan 27, 2017 | — |
| S-1/A | Amended registration statement | Jan 26, 2017 | — |
| CORRESP | Letter to the SEC | Jan 25, 2017 | — |
| S-1/A | Amended registration statement | Jan 19, 2017 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 28, 2016 | Dec 27, 2016 |
| S-1/A | Amended registration statement | Dec 21, 2016 | — |
| CORRESP | Letter to the SEC | Dec 19, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2016 | Dec 8, 2016 |
| S-1/A | Amended registration statement | Dec 6, 2016 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 30, 2016 | Nov 23, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Nov 28, 2016 | Nov 28, 2016 |
| CORRESP | Letter to the SEC | Nov 22, 2016 | — |
| S-1/A | Amended registration statement | Nov 22, 2016 | — |
| DEFA14A | Additional proxy material | Nov 18, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2016 | Nov 14, 2016 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2016 | Nov 10, 2016 |
| 10-Q | Quarterly report | Nov 9, 2016 | Sep 30, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2016 | Nov 2, 2016 |
| DEF 14A | Proxy statement | Nov 2, 2016 | Nov 28, 2016 |
| UPLOAD | Letter from the SEC | Nov 1, 2016 | — |
| CORRESP | Letter to the SEC | Nov 1, 2016 | — |
| S-1/A | Amended registration statement | Nov 1, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2016 | Oct 27, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2016 | Oct 25, 2016 |
| UPLOAD | Letter from the SEC | Oct 24, 2016 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVCT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Knoxville, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 315545
- Former names
- PROVECTUS PHARMACEUTICALS INC (until Dec 18, 2013); PROVECTUS PHARMACEUTICAL INC (until May 15, 2002); ZAMAGE DIGITAL IMAGING INC (until Apr 1, 2002); SPM GROUP INC (until Nov 14, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.